Prosecution Insights
Prosecution Insights
Tech Center 1600 • Art Units: 1654 1675
This examiner grants 63% of resolved cases
Tara L. Martinez is an examiner in Tech Center 1600 and Art Unit 1654. She has overseen 610 resolved cases. Her allowance rate is 62.6 percent. This rate serves as the baseline for the probability of success for applications under her review. The 62.6 percent figure is derived from the sample of 610 resolved cases.
The interview lift for this examiner is 65.4 percent. This 65.4 percent lift indicates an increase in the likelihood of allowance when an interview is conducted. For practitioners, the 65.4 percent figure suggests that verbal advocacy is a component of a successful prosecution strategy. This lift is one of the impactful metrics in her profile.
The median days to allowance is 1064. This 1064-day median represents the typical timeframe for reaching a patent grant. Understanding the 1064-day duration helps applicants in Art Unit 1654 plan their prosecution timelines. This median and the 62.6 percent allowance rate together define the expected path for applications on her docket.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18275586 | BINDING PEPTIDES AND USES THEREOF | Non-Final OA | The Johns Hopkins University |
| 18824181 | NON-RECOMBINANT HUMAN INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN CONCENTRATE | Non-Final OA | Siemens Healthcare Diagnostics Inc. |
| 18770880 | HEME-BINDING SMALL PEPTIDE | Non-Final OA | Massachusetts Institute of Technology |
| 17736946 | HIGH CONCENTRATION CELL PENETRATING CASPASE INHIBITOR CONJUGATES, COMPOSITIONS AND METHODS THEREOF | Non-Final OA | THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK |
| 18841685 | USE OF SU3327 IN PREPARATION OF MEDICAMENT FOR ENHANCING EFFICACY OF POLYMYXIN AGAINST BACTERIAL INFECTION | Non-Final OA | CHINA AGRICULTURAL UNIVERSITY |
| 16093758 | COMPOSITIONS AND METHODS FOR SELECTIVE PROTEIN EXPRESSION | Final Rejection | The Trustees of the University of Pennsylvania |
| 18017982 | TREATMENTS FOR CANCERS HAVING KRAS MUTATIONS | Final Rejection | City of Hope |
| 18566294 | METHODS OF INHIBITING BOVINE MASTITIS DURING THE DRY PERIOD | Non-Final OA | ELANCO US INC. |
| 18247093 | NOVEL ZINC FINGER PROTEIN TRANSCRIPTION FACTORS FOR REPRESSING ALPHA-SYNUCLEIN EXPRESSION | Non-Final OA | Sangamo Therapeutics, Inc. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy